Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 21332334)

Published in Ren Fail on January 01, 2011

Authors

Ana Borges1, Margarida Borges, João Fernandes, Henrique Nascimento, Maria Sameiro-Faria, Vasco Miranda, Flávio Reis, Luis Belo, Elisio Costa, Alice Santos-Silva

Author Affiliations

1: Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal.

Articles by these authors

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ (2006) 3.68

Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol (2012) 2.02

Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia (2011) 1.58

Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model. Mediators Inflamm (2011) 1.42

Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol (2011) 1.41

Incidence and prevalence of hypercholesterolemia in Portugal: a systemic review. Part II. Rev Port Cardiol (2003) 1.38

Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat). Exp Diabetes Res (2011) 1.23

Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. Infect Immun (2005) 1.21

Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm (2010) 1.17

Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis (2002) 1.16

The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol (2012) 1.14

Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol (2005) 1.13

Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus. Oxid Med Cell Longev (2012) 1.06

Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit (2007) 1.04

The effect of green tea in oxidative stress. Clin Nutr (2006) 1.03

Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood. J Pregnancy (2012) 1.02

Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol (2013) 1.00

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol (2009) 0.99

Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy (2003) 0.99

LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis (2004) 0.98

Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol (2008) 0.97

Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review. Part I. Rev Port Cardiol (2003) 0.96

Anti-inflammatory activity of chitooligosaccharides in vivo. Mar Drugs (2010) 0.94

Trypanosoma cruzi-Induced Host Immune System Dysfunction: A Rationale for Parasite Immunosuppressive Factor(s) Encoding Gene Targeting. J Biomed Biotechnol (2001) 0.93

Implication of low HDL-c levels in patients with average LDL-c levels: a focus on oxidized LDL, large HDL subpopulation, and adiponectin. Mediators Inflamm (2013) 0.91

Leukocyte Count versus C-Reactive Protein Levels in Obese Portuguese Patients Aged 6-12 Years Old. Open Biochem J (2010) 0.91

Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review. Part III. Rev Port Cardiol (2003) 0.90

Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol (2008) 0.89

Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodial Int (2010) 0.88

Lipid profile in Portuguese obese children and adolescents: interaction of apolipoprotein E polymorphism with adiponectin levels. Arch Pediatr Adolesc Med (2009) 0.88

Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. Dis Markers (2013) 0.88

Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J Leukoc Biol (2004) 0.87

Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients. Br J Haematol (2010) 0.87

Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker. Cardiovasc Diabetol (2013) 0.87

Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis (2008) 0.87

Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria. BJOG (2002) 0.86

Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis. Cancer Biol Ther (2009) 0.86

Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients. Ren Fail (2013) 0.86

The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. J Investig Med (2014) 0.86

Type of vascular access and location in online hemodiafiltration and its association with patient's perception of health-related quality of life. J Vasc Access (2013) 0.86

GeneBrowser 2: an application to explore and identify common biological traits in a set of genes. BMC Bioinformatics (2010) 0.86

Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping. Cardiovasc Toxicol (2009) 0.85

Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol (2008) 0.85

Fetal lipoprotein changes in pre-eclampsia. Acta Obstet Gynecol Scand (2008) 0.85

Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J (2012) 0.85

Differential effects of acute (extenuating) and chronic (training) exercise on inflammation and oxidative stress status in an animal model of type 2 diabetes mellitus. Mediators Inflamm (2011) 0.84

Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer. Biomed Res Int (2013) 0.84

Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects. Blood Cells Mol Dis (2012) 0.83

Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index. Am J Med Sci (2012) 0.83

Effects of olive oil polyphenols on erythrocyte oxidative damage. Mol Nutr Food Res (2009) 0.83

Effects of chitooligosaccharides on human red blood cell morphology and membrane protein structure. Biomacromolecules (2008) 0.83

Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients. Blood Cells Mol Dis (2010) 0.82

Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration. Qual Life Res (2014) 0.82

Apoptosis and autophagy in breast cancer cells following exemestane treatment. PLoS One (2012) 0.82

Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol (2004) 0.82

Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodial Int (2013) 0.82

Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy. Growth Factors (2009) 0.81

New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging. Dis Markers (2013) 0.81

Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model. BJU Int (2011) 0.81

The burden of disease and the cost of illness attributable to alcohol drinking--results of a national study. Alcohol Clin Exp Res (2010) 0.81

Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thromb Res (2008) 0.81

Band 3 as a marker of erythrocyte changes in pregnancy. Eur J Haematol (2002) 0.81

Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene. Hemodial Int (2012) 0.80

Mycobacterium parascrofulaceum in acidic hot springs in Yellowstone National Park. Appl Environ Microbiol (2007) 0.80

Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci (2009) 0.80

Biocompatibility and hemocompatibility of polyvinyl alcohol hydrogel used for vascular grafting--In vitro and in vivo studies. J Biomed Mater Res A (2014) 0.80

Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model. Mar Drugs (2012) 0.79

Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure. Ren Fail (2010) 0.79

Changes in red blood cells membrane protein composition during hemodialysis procedure. Ren Fail (2008) 0.79

Cytotoxicity and genotoxicity of chitooligosaccharides upon lymphocytes. Int J Biol Macromol (2011) 0.79